CD44 and neoplasm: In this study, we investigated the effect of the anti-tumor agent paclitaxel (PTX) conjugated to hyaluronic acid (HA), the CD44 ligand, and a molecule named Oncofid-P20 (Onco-P20) on skin carcinoma cells, dermal fibroblasts, and CAFs.